CVS HEALTH (CVS) Stock: Buy, Sell, or Hold?
CVS - CVS HEALTH CORPORATION
$94.48
1.03 (1.10%)
▲
5d:
+2.05%
30d:
+10.04%
90d:
-12.31%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 04, 2026
11d
Get Alerted When CVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CVS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CVS shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$117.91
Based on 5.1% avg growth
INTRINSIC VALUE TODAY
$73.22
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CVS is currently trading at $94.48, which is considered extended relative to its 30-day fair value range of $86.10 to $92.47. The stock's valuation (Forward PE: 11.1) is in line with its historical norms (10.8). At these levels, the market is pricing in 0.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CVS is in a strong downtrend. The price is approaching resistance at $95.26. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CVS scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $115.48 (+22.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CVS is in a strong downtrend. The price is approaching resistance at $95.26. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CVS scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $115.48 (+22.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$86.10 -
$92.47
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
29.5%
Protect Your Profits
Holding CVS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (10/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.2% below Wall St target ($115.48)
- NEUTRAL: Market pricing in 0.9% annual earnings growth - fairly valued
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$86.10 -
$92.47
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$85.80
Resistance Level
$95.26
Current Trend
Strong Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.07
Wall Street Target
$115.48
(+22.2%)
Revenue Growth (YoY)
7.1%
Earnings Growth (YoY)
188.8%
Profit Margin
1.2%
Valuation Premium vs History
+0.9% premium
PE vs Historical
11.1 vs 10.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.9%
(market-implied from PE analysis)
1-Year Target
$95.33
(+1%)
2-Year Target
$96.19
(+2%)
3-Year Target
$97.05
(+3%)
3-Yr Target (if PE normalizes)
(PE: 11→11)
PE COMPRESSION
$94.69
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 6.1%)
$202.58
(+114%)
Base:
(SPY PE: 11.1, Growth: 6.1%)
$112.91
(+20%)
Bear:
(PE: 9.4, Growth: 6.1%)
$95.98
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 24.59 | Current EPS (TTM): $3.80
Bull Case
$205.59
(+118%)
Analyst growth 100.0%, PE expands to 27.1
Base Case
$186.90
(+98%)
Market implied 100.0%, PE stable at 24.6
Bear Case
$63.55
(-33%)
Severe decline -20.0%, PE contracts to 20.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 23, 2026 6:00 AM ET
Data refreshes hourly during market hours. Next update: 7:00 AM
Data refreshes hourly during market hours. Next update: 7:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
26 analysts |
$477 | 29 SELL |
|
HUM
Humana Inc |
BUY
26 analysts |
$465 | 37 SELL |
|
CI
Cigna Corp |
STRONG BUY
24 analysts |
$342 | 27 SELL |
|
ELV
Elevance Health Inc |
BUY
22 analysts |
$452 | 31 SELL |
|
ALHC
Alignment Healthcare LLC |
STRONG BUY
14 analysts |
$13 | 52 HOLD |
Advanced CVS Option Strategies
Professional options setups generated by AI based on today's CVS price and gamma walls.
